210 related articles for article (PubMed ID: 28834907)
21. Prevalence of glucose intolerance in rheumatoid arthritis patients at a tertiary care centre in Haryana.
Rajput R; Dangi A; Singh H
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S1013-S1016. PubMed ID: 28751150
[TBL] [Abstract][Full Text] [Related]
22. Impaired fasting glucose in hypertensive patients: prevalence and cross-sectional analysis of associations with cardiovascular disease.
Tziomalos K; Spanou M; Baltatzi M; Efthymiou E; Psianou K; Papastergiou N; Iliadis F; Didangelos TP; Savopoulos C; Hatzitolios AI
Diabetes Technol Ther; 2013 Jun; 15(6):475-80. PubMed ID: 23544673
[TBL] [Abstract][Full Text] [Related]
23. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.
Ruscitti P; Masedu F; Alvaro S; Airò P; Battafarano N; Cantarini L; Cantatore FP; Carlino G; D'Abrosca V; Frassi M; Frediani B; Iacono D; Liakouli V; Maggio R; Mulè R; Pantano I; Prevete I; Sinigaglia L; Valenti M; Viapiana O; Cipriani P; Giacomelli R
PLoS Med; 2019 Sep; 16(9):e1002901. PubMed ID: 31513665
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study.
de Resende Guimarães MFB; Rodrigues CEM; Gomes KWP; Machado CJ; Brenol CV; Krampe SF; de Andrade NPB; Kakehasi AM
Adv Rheumatol; 2019 Oct; 59(1):44. PubMed ID: 31619287
[TBL] [Abstract][Full Text] [Related]
26. Dose-response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case-control study.
Li G; Chi W; Bai B; Li Y; Wei T; Fu L
BMJ Open; 2019 Jul; 9(7):e028011. PubMed ID: 31278101
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study.
Monk HL; Muller S; Mallen CD; Hider SL
BMC Fam Pract; 2013 Oct; 14():150. PubMed ID: 24106825
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L
Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
Dessein PH; Stanwix AE; Joffe BI
Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
[TBL] [Abstract][Full Text] [Related]
31. Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study.
Šalamon L; Morović-Vergles J; Marasović-Krstulović D; Kehler T; Šakić D; Badovinac O; Vlak T; Novak S; Štiglić-Rogoznica N; Hanih M; Bedeković D; Grazio S; Kadojić M; Milas-Ahić J; Prus V; Stamenković D; Šošo D; Anić B; Babić-Naglić Ð; Gamulin S
Rheumatol Int; 2015 Dec; 35(12):2047-57. PubMed ID: 26059944
[TBL] [Abstract][Full Text] [Related]
32. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study.
Kokkonen H; Stenlund H; Rantapää-Dahlqvist S
Arthritis Res Ther; 2017 Jun; 19(1):148. PubMed ID: 28666478
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
[TBL] [Abstract][Full Text] [Related]
35. Profile of diabetes and cardiovascular risk factors in adults Anjouan Island (Comoros).
Ali RAB; Hannoun Z; Harraqui K; Zeghari L; Aboussaleh Y; Mohamed S; Anssoufouddine M; Bour A
Pan Afr Med J; 2019; 33():140. PubMed ID: 31558938
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of metabolic syndrome in rheumatoid arthritis patients from Northeastern Brazil: Association with disease activity.
Gomes KWP; Luz AJP; Felipe MRB; Beltrão LA; Sampaio AXC; Rodrigues CEM
Mod Rheumatol; 2018 Mar; 28(2):258-263. PubMed ID: 28486047
[TBL] [Abstract][Full Text] [Related]
37. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
Janghorbani M; Amini M
Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
[TBL] [Abstract][Full Text] [Related]
38. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
[TBL] [Abstract][Full Text] [Related]
39. Change in Cardiovascular Health and Incident Type 2 Diabetes and Impaired Fasting Glucose: The Whitehall II Study.
Climie RE; van Sloten TT; Périer MC; Tafflet M; Fayosse A; Dugravot A; Singh-Manoux A; Empana JP
Diabetes Care; 2019 Oct; 42(10):1981-1987. PubMed ID: 31416895
[TBL] [Abstract][Full Text] [Related]
40. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
